RxDoctor Payments Data

Aaron Rogers

Family · Farmington, NMNPI 1881096642

Payments from drug & device makers

$2,952in general payments, 2019–2025

Across 157 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$400
  • Lilly USA, LLC$385
  • Boehringer Ingelheim$350
  • AbbVie$283
  • Astellas Pharma US Inc$276
  • Novo Nordisk$218
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$2,952100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,952 in reported general payments places this provider in the 90th percentile of 1,080 family providers in New Mexico.

See all family providers in New Mexico

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban37$32,212
JardianceEmpagliflozin27$28,800
FarxigaDapagliflozin Propanediol27$24,691
XareltoRivaroxaban16$24,231
MounjaroTirzepatide18$22,702
JanuviaSitagliptin Phosphate16$20,315
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$18,324
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$13,748
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog36$8,435
SymbicortBudesonide/Formoterol Fumarate11$4,530
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$3,591
Atorvastatin Calcium264$3,387
Boostrix TdapDiphth,pertuss(Acell),tet Vac45$3,158
ShingrixVaricella-Zoster Ge/As01b/Pf11$2,439
Metoprolol Succinate99$1,765

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$400$42,96860 claims
PfizerEliquis$158$32,21237 claims
Boehringer IngelheimJardiance$350$28,80027 claims
Johnson & JohnsonXarelto$97$24,23116 claims
Lilly USA, LLCMounjaro$385$22,70218 claims
GSKTrelegy Ellipta, Shingrix$109$20,76233 claims
MerckJanuvia$70$20,31516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,080 family providers in New Mexico.

Other family in Farmington

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →